Inventor profile of:

Xianqi Kong

City:

Dollard-des-Ormeaux

Country:

Canada

Published Applications:

70

Last publication date:

2026-02-05

Top Assignees for applications by Xianqi Kong

The entities that hold a legal rights for patent applications filed by inventor Kong Xianqi:

Recent patent applications by Kong Xianqi

Xianqi Kong from Dollard-des-Ormeaux, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05
US20260035342A1
Chemistry; metallurgy

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

#2 | 2025-11-20
US20250353870A1
Chemistry; metallurgy

GLUCOSAMINE DERIVATIVES AND PHARMACEUTICAL USES THEREOF

#3 | 2025-11-20
US20250352516A1
Human necessities

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DISEASE

#4 | 2025-05-29
US20250170161A1
Human necessities

INHIBIN SUBUNIT BETA E INHIBITOR AND METHODS OF USE THEREOF

#5 | 2024-07-25
US20240246963A1
Chemistry; metallurgy

BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF

#6 | 2024-07-18
US20240239813A1
Chemistry; metallurgy

KRAS INHIBITORS AND PHARMACEUTICAL USES THEREOF

#7 | 2024-06-13
US20240190859A1
Chemistry; metallurgy

STABLE HEAVY ISOTOPES IN AMIDE FUNCTIONAL GROUPS AND USES THEREOF

#8 | 2024-05-16
US20240158343A1
Chemistry; metallurgy

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

#9 | 2024-04-11
US20240116952A1
Chemistry; metallurgy

KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF

#10 | 2024-02-29
US20240065990A1
Human necessities

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#11 | 2024-02-22
US20240059712A1
Chemistry; metallurgy

BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF

#12 | 2024-02-15
US20240051982A1
Chemistry; metallurgy

Glucosamine derivatives for the prevention or treatment of joint disorders

#13 | 2024-02-15
US20240050577A1
Human necessities

CDK INHIBITORS AND PHARMACEUTICAL USES THEREOF

#14 | 2024-01-25
US20240024346A1
Human necessities

CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF

#15 | 2024-01-04
US20240000761A1
Human necessities

STABLE HEAVY ISOTOPES IN AMIDE FUNCTIONAL GROUPS AND USES THEREOF

#16 | 2023-10-12
US20230321253A1
Human necessities

BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF

#17 | 2023-09-21
US20230295213A1
Chemistry; metallurgy

CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF

#18 | 2023-09-21
US20230295079A1
Chemistry; metallurgy

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

#19 | 2023-07-20
US20230227488A1
Chemistry; metallurgy

GLUCOSAMINE DERIVATIVES AND PHARMACEUTICAL USES THEREOF

#20 | 2023-01-19
US20230019098A1
Human necessities

BIVALENT COMPOUNDS, CONJUGATES AND USES THEREOF

#21 | 2022-06-30
US20220204541A1
Chemistry; metallurgy

Prodrugs of a CDK inhibitor for treating cancers

#22 | 2022-06-30
US20220202778A1
Human necessities

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DISEASE

#23 | 2022-01-06
US20220002285A1
Chemistry; metallurgy

Stable heavy isotopes in amide functional groups and uses thereof

#24 | 2021-12-16
US20210386693A1
Human necessities

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#25 | 2021-11-11
US20210347731A1
Chemistry; metallurgy

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

#26 | 2021-05-13
US20210139526A1
Chemistry; metallurgy

CD73 inhibitors and pharmaceutical uses thereof

#27 | 2021-03-18
US20210079033A1
Chemistry; metallurgy

Glucosamine derivatives for the prevention or treatment of joint disorders

#28 | 2021-03-18
US20210078970A1
Chemistry; metallurgy

PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER

#29 | 2020-10-29
US20200339615A1
Chemistry; metallurgy

Prodrugs of a CDK inhibitor for treating cancers

#30 | 2020-08-13
US20200253897A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#31 | 2020-07-16
US20200223793A1
Chemistry; metallurgy

Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof

#32 | 2020-03-12
US20200078388A1
Human necessities

CD73 inhibitors and pharmaceutical uses thereof

#33 | 2020-01-09
US20200009086A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#34 | 2019-06-20
US20190185502A1
Chemistry; metallurgy

Glucosamine derivatives and pharmaceutical uses thereof

#35 | 2018-09-27
US20180273471A1
Chemistry; metallurgy

Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof

#36 | 2017-04-06
US20170095430A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#37 | 2016-08-04
US20160220519A1
Human necessities

AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN

#38 | 2015-09-24
US20150266814A1
Chemistry; metallurgy

METHODS, COMPOUNDS, AND COMPOSITIONS FOR DELIVERING 1,3-PROPANEDISULFONIC ACID

#39 | 2014-11-06
US20140329746A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES

#40 | 2014-08-07
US20140220122A1
Chemistry; metallurgy

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#41 | 2014-06-19
US20140171507A1
Chemistry; metallurgy

Amino acid derivatives for the treatment of neuropathic pain

#42 | 2014-04-17
US20140107027A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES

#43 | 2012-08-16
US20120208876A1
Human necessities

AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN

#44 | 2012-08-16
US20120208850A1
Chemistry; metallurgy

Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid

#45 | 2012-01-19
US20120015911A1
Chemistry; metallurgy

Method and compositions for treating amyloid-related diseases

#46 | 2011-11-17
US20110281951A1
Human necessities

Compositions and methods for treating amyloidosis

#47 | 2011-01-27
US20110021813A1
Chemistry; metallurgy

PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF

#48 | 2010-07-29
US20100190753A1
Chemistry; metallurgy

Methods and Compositions for Treating Amyloid-Related Diseases

#49 | 2010-05-06
US20100113591A1
Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#50 | 2009-04-16
US20090099100A1
Human necessities

Compositions and methods for treating amyloidosis

#51 | 2008-09-18
US20080227767A1
Human necessities

Methods and compounds for inhibiting amyloid deposits

#52 | 2008-07-01
US10429198
-

Methods and compounds for inhibiting amyloid deposits

#53 | 2008-06-19
US20080146642A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#54 | 2008-01-31
US20080027097A1
Chemistry; metallurgy

PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF

#55 | 2008-01-17
US20080015180A1
Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#56 | 2008-01-03
US20080004244A1
Human necessities

Phosphono-carboxylate compounds for treating amyloidosis

#57 | 2007-06-14
US20070135337A2
Human necessities

Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases

#58 | 2007-01-25
US20070021483A1
Chemistry; metallurgy

Amidine derivatives for treating amyloidosis

#59 | 2007-01-11
US20070010573A1
Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#60 | 2006-10-05
US20060223855A1
Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#61 | 2006-08-17
US20060183800A1
Chemistry; metallurgy

Methods and fluorinated compositions for treating amyloid-related diseases

#62 | 2006-07-27
US20060167057A1
Chemistry; metallurgy

Compounds for the treatment of CNS and amyloid associated diseases

#63 | 2006-06-22
US20060135479A1
Human necessities

Phosphono-carboxylate compounds for treating amyloidosis

#64 | 2005-08-18
US20050182118A1
Human necessities

Amidine derivatives for treating amyloidosis

#65 | 2005-06-30
US20050143462A1
Human necessities

Pharmaceutical drug candidates and methods for preparation thereof

#66 | 2005-05-05
US20050096385A1
Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#67 | 2005-04-28
US20050090439A1
Human necessities

Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases

#68 | 2005-03-03
US20050048000A1
Human necessities

Amyloid targeting imaging agents and uses thereof

#69 | 2005-02-17
US20050038117A1
Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#70 | 2005-02-17
US20050038000A1
Human necessities

Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases

InventorID:

728624 ⎘